Skip to main content

Table 1 Clinical data from TCGA patients

From: Prediction of chemo-response in serous ovarian cancer

 

CR

IR

p-value*

Number of Patients

292

158

 

Age (Avg.)

60

59.6

N.S.

Grade

  

N.S.

Grade 1

4

1

 

Grade 2

35

18

 

Grade 3

246

135

 

Stage

  

p < 0.01

Stage I

10

3

 

Stage II

19

1

 

Stage III

224

123

 

Stage IV

39

29

 

Surgical outcome

  

N.S.

Optimal (<1 cm residual)

207

92

 

Suboptimal (>1 cm residual)

52

57

 

Optimal Treatment

  

p < 0.001

Optimal (Surgery + 6 cycles)

179

66

 

Suboptimal

113

92

 
  1. *Multivariable analysis of TCGA clinical variables: Only FIGO stage and optimal treatment (including optimal surgery AND 6 cycles of platinum-based chemotherapy) were independently associated with chemo-response in serous OVCA
Back to article page

Molecular Cancer

ISSN: 1476-4598